Letter

Resistance to HIV drugs in UK may be lower in some areas

BMJ 2006; 332 doi: 10.1136/bmj.332.7534.179-c (Published 19 January 2006)
Cite this as: BMJ 2006;332:179.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Julie M Fox, clinical lecturer (julie.fox@imperial.ac.uk),
  2. Sarah Fidler, clinical senior lecturer,
  3. Jonathan Weber, Jefferriss professor
  1. Section of Infectious Diseases, Faculty of Medicine, Imperial College, London W2 1PG
  2. Section of Infectious Diseases, Faculty of Medicine, Imperial College, London W2 1PG

    Editor—The UK Group on Transmitted HIV Drug Resistance reports an estimated prevalence of transmitted HIV drug resistance of 14.2% between 1996 and 2003 which is increasing over time.1 Using the same definition of drug resistance as the UK group, a study of primary HIV infection at St Mary's Hospital, London, showed that the prevalence and annual incidence of transmitted drug resistance have remained …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular